NeovacsALNEV 
$1.254.68%24h
4.68%24h
Global rank2907
Market cap$4.40B
Change 7d-20.28%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Neovacs (ALNEV)
As of January 2025, Neovacs has a market cap of $4.40B. This makes Neovacs the world's 2907th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Neovacs from 2012 to 2024
-
Value:-
Market cap history of Neovacs from 2012 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.51B | 890000.00% |
| 2023 | $730.82K | -100.00% |
| 2022 | $122.78B | -99.92% |
| 2021 | $146.16T | -98.34% |
| 2020 | $8828.32T | -47.93% |
| 2019 | $16955.05T | -71.43% |
| 2018 | $59342.69T | -55.87% |
| 2017 | $134471.12T | -43.21% |
| 2016 | $236786.10T | -27.31% |
| 2015 | $325753.68T | -4.17% |
| 2014 | $339916.88T | 441599.27% |
| 2013 | $76.96T | -2.42% |
| 2012 | $78.87T | - |
ALNEV Market Cap Today is $4.40B 4.68% - 23 Jan 2025
View largest stocks by market cap 
